Oleoylethanolamide

油酰乙醇酰胺

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameOleoylethanolamide
Drug Alias Name油酰乙醇胺
ClassificationSmall molecules
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsAlcoholismPrader-Willi Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNutriForward LLC
China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of South Carolina
Inactive CompaniesNutriForward LLC
Active IndicationsAlcoholism
Inactive IndicationsPrader-Willi Syndrome

Other Information

ATC CodeN/A
Related LinksN/A